Epidermal growth factor receptor expression in 780 breast cancer patients: A reappraisal of the prognostic value based on an eight-year median follow-up

Annals of Oncology

Volumn 12, Issue 6, 2001, Pages 841-846

  Ferrero, J M ^a   Ramaioli, A ^a   Largillier, R ^a   Formento, J L ^a   Francoual, M ^a   Ettore, F ^a   Namer, M ^a   Milano, G ^a  

^a CENTRE ANTOINE LACASSAGNE   (France)

Author keywords

Breast cancer; Epidermal growth factor receptor; Prognostic markers

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTRADIOL RECEPTOR; TAMOXIFEN;

ADULT; AGE; AGED; ARTICLE; ASSAY; AXILLARY LYMPH NODE; BREAST CANCER; BREAST SURGERY; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG TARGETING; FOLLOW UP; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIGAND BINDING; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; METASTASIS; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STATISTICAL ANALYSIS; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, ESTRADIOL; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0034948188     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011183421477     Document Type: Article

References (32)

1. Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene
2. Cancer of the breast: Molecular biology of breast cancer
3. ERB B2 oncogene in human breast cancer and its clinical significance
4. ErbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer
5. The prognostic value of epidermal growth factor receptor in primary breast cancer: Results of a 10-year follow-up study
6. Identification of epidermal growth factor receptor and C-erbB2 pathways inhibitors by correlation with gene expression patterns
7. The epidermal growth factor receptor and its inhibition in cancer therapy
8. Targeting of epidermal growth factor receptor and protein kinase A: Molecular basis and therapeutic applications
9. Multinational study of the efficacy and safety of humanized anti-HER 2 monoclonal antibody in women who have HER 2 - Overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease
10. Histological grading and prognosis in breast cancer
11. Simultaneous micro-measurement of steroid receptors in breast cancer
12. Determination of oestrogen receptors by enzyme immunoassay. Technical differences between laboratories and their consequences
13. Comparison of ligand binding assay and enzyme immunoassay of estrogen receptor in human breast cancer cytosols
14. Epidermal growth factor receptor assay: Validation of a single point method and application to breast cancer
15. Evaluation of survival data and two new rank order statistics arising in its consideration
16. Covariance analysis of censored survival data
17. Regression models and life take
18. Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies
19. Epidermal growth factor receptor tyrosine Kinase-structure-activity relationships and antitumor activity of novel quinazolines
20. Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival
21. Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer
22. Epidermal growth factor receptor and labeling index are independant prognostic factors in glial tumor outcome
23. The epidermal growth factor receptor as a prognostic factor: Results of 370 patients and review of 3009 patients
24. Presence of epidermal growth factor receptors as an indicator of poor prognosis in patients with breast cancer
25. The clinical significance of epidermal growth factor receptor in human breast cancer: A review on 5232 patients
26. Epidermal growth factor receptor and prognosis in human breast cancer: A prospective study
27. Epidermal growth factor receptor in breast cancer: Correlation of quantitative immunocytochemical assays to prognostic factors
28. Prognostic value of solubilized fraction of EGF receptors in primary breast cancer using an immunoenzymatic assay-a retrospective study
29. Correlation of the EGF-receptor with cell kinetic and classical prognostic factors in breast cancer
30. Effect of sodium butyrate on estrogen receptor and epidermal growth factor receptor gene expression in human breast cancer cell lines
31. Ectopic expression of epidermal growth factor receptors induces hormone independence in ZR-75-1 human breast cancer cells